Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1319
Revised: August 14, 2024
Accepted: August 15, 2024
Published online: September 19, 2024
Processing time: 48 Days and 19.1 Hours
Pediatric abdominal infection is a common but serious disease that requires timely and effective treatment. In surgical treatment, accurate diagnosis and rational application of antibiotics are the keys to improving treatment effects.
To investigate the effect of broad-spectrum bacterial detection on postoperative antibiotic therapy.
A total of 100 children with abdominal infection who received surgical treatment in our hospital from September 2020 to July 2021 were grouped. The observation group collected blood samples upon admission and sent them for broad-spectrum bacterial infection nucleic acid testing, and collected pus or exudate during the operation for bacterial culture and drug sensitivity testing; the control group only sent bacterial culture and drug sensitivity testing during the operation.
White blood cell count, C-reactive protein, procalcitonin, 3 days after surgery, showed better postoperative index than the control group (P < 0.05). The hospital stay in the observation group was significantly shorter than that in the control group. The hospitalization cost in the observation group was significantly lower than that in the control group, and the difference between the two groups was statistically significant (P < 0.05).
Early detection of broad-spectrum bacterial infection nucleic acids in pediatric abdominal infections can help identify pathogens sooner and guide the appropriate use of antibiotics, improving treatment outcomes and reducing medical costs to some extent.
Core Tip: Preliminary nucleic acid detection of broad-spectrum bacterial infections has important clinical significance in the surgical treatment of abdominal infections in children. The results of this study show that compared with only intraoperative bacterial culture + drug sensitivity testing, early broad-spectrum bacterial infection nucleic acid testing can significantly improve patients' treatment effects, mental health and recovery quality, and reduce medical costs. First of all, conducting broad-spectrum bacterial infection nucleic acid detection in advance can help identify pathogens earlier and guide the rational use of antibiotics, thereby effectively controlling the development of infection. The postoperative infection indicators of the patients in the observation group were significantly lower than those of the control group, and the hospitalization time and costs were also significantly reduced, which further verified the clinical value of nucleic acid testing in advance. This research result has guiding significance for clinical practice and also provides an important reference for future related research.